| Previous Close | 0.665 |
| Open | 0.000 |
| Bid | 0.000 x 0 |
| Ask | 0.000 x 0 |
| Day's Range | 0.000 - 0.000 |
| 52 Week Range | |
| Volume | 0 |
| Avg. Volume | 9,263 |
| Market Cap | 20.77M |
| Beta | 1.03 |
| PE Ratio (TTM) | -19.56 |
| EPS (TTM) | -0.03 |
| Earnings Date | Oct 17, 2017 - Oct 23, 2017 |
| Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 1.50 |
Capital Cube•7 days agoNanophase Technologies Corp. :NANX-US: Earnings Analysis: Q2, 2017 By the Numbers : September 18, 2017
Categories: Yahoo FinanceGet free summary analysis Nanophase Technologies Corp. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Nanophase Technologies Corp. – Arrowhead Pharmaceuticals, Inc. and Quaker Chemical Corporation (ARWR-US and KWR-US) that have also reported for this period. Highlights Summary numbers: Revenues of USD 3.58 ... Read more (Read more...)
- Thomson Reuters StreetEvents•last month
Edited Transcript of NANX earnings conference call or presentation 27-Jul-17 3:00pm GMT
Q2 2017 Nanophase Technologies Corp Earnings Call
- ACCESSWIRE•2 months ago
Investor Network: NANOPHASE TECHNOLOGIES CORPORATION to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / July 27, 2017 / NANOPHASE TECHNOLOGIES CORPORATION (NASDAQ: NANX ) will be discussing their earnings results in their Q2 Earnings Call to be held on Thursday, July 27, 2017 ...
